Trust Your Gut: Improving the Physician Assistant’s Acumen in Identifying and Managing Irritable Bowel Syndrome and Chronic Idiopathic Constipation
Release Date: October 15, 2015
Last Reviewed: October 3, 2015
Expiration Date: October 15, 2016
Time to Complete Activity:  1 hour

*This activity expired for credit on October 15, 2016 and is no longer available for credit
Clinical Faculty
Kellie Bunn, PA-C, MHS (Chair)
Physician Assistant
Chapel Hill Primary Care
Drossman Gastroenterology
Chapel Hill, NC
Brooks D. Cash, MD
Professor of Medicine
Division of Gastroenterology
University of South Alabama
Mobile, AL
Lucinda A. Harris, MD, MS
Associate Professor of Medicine
Division of Gastroenterology and Hepatology
Mayo College of Medicine
Scottsdale, AZ
Patient Faculty
Gail S. Cobb
Burlington, NC
Carly Herbert
Atlanta, GA
This activity is provided by Paradigm Medical Communications, LLC.  
Target Audience
This activity has been designed to address the educational needs of physician assistants (PAs) with an interest in the diagnosis and management of irritable bowel syndrome (IBS) and chronic idiopathic constipation (CIC). This activity will also benefit other healthcare providers (HCPs) interested in the diagnosis and management of IBS and CIC.
Learning Objectives
Upon proper completion of this activity, participants should be better able to:
  • Recognize symptoms that should be used to “rule in” the diagnoses of IBS and CIC, according to Rome III criteria.
  • Describe the evidence-based therapies available to treat patients with IBS and CIC.
  • Discuss strategies to improve treatment adherence among patients with IBS and CIC.
Table of Contents
Chapter 1: Diagnosing Irritable Bowel Syndrome and Chronic Idiopathic Constipation
Chapter 2: Personalized Therapy for Patients with Constipation-Predominant Irritable Bowel Syndrome and/or Chronic Idiopathic Constipation
Chapter 3: Personalized Therapy for Patients with Diarrhea-Predominant Irritable Bowel Syndrome
Chapter 4: Strategies for Improving the Patient Experience
Physician Accreditation Statement
Paradigm Medical Communications, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Physician Credit Designation Statement
Paradigm Medical Communications, LLC designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physician Assistant Continuing Education
This program has been reviewed and is approved for a maximum of 1.00 hours of AAPA Category 1 CME credit by the Physician Assistant Review Panel. Approval is valid for one year from the issue date of 10/15/2015 . Participants may submit the post-test at any time during that period.

This program was planned in accordance with AAPA's CME Standards for Enduring Material Programs and for Commercial Support of Enduring Material Programs.

Disclosure of Commercial Support
This activity is supported by educational grants from Allergan, Inc, and Prometheus Laboratories, Inc.
Instructions for Participation
To receive a CME certificate of participation, you should:
  • Follow instructions to register or log in with your professional information and complete the pre-activity assessment
  • View the online activity in its entirety.
  • Complete and submit the online posttest and evaluation. You must answer 70% of the posttest questions correctly to earn credit. You will have unlimited opportunities to successfully complete the posttest.
A certificate of participation will be available for download/printing immediately following your successful completion of the posttest and evaluation.

Successful completion of the post-test is required to earn Category 1 CME credit. Successful completion is defined as a cumulative score of at least 70 percent correct.

For questions regarding CME credit, contact the Paradigm CME Department at (845) 398-5949.
There is no fee required for participation in this activity.

Hardware/Software Requirements
Supported Browsers:
For Desktops (Windows/Mac)
Internet Explorer 9 or higher, Firefox 28 or higher, Safari 5.1 or higher, Google Chrome 31 or higher, Opera 21 or higher
For Tablets (iPad/Android/Surface)
iOS Safari 4 or higher, Android 2.3 or higher, IE Mobile 10 or higher
Technical Support: If you have any technical problems or playback issues email us at
In accordance with ACCME and AAPA requirements on disclosure, faculty and contributors are asked to disclose any relationships with commercial interests associated with the area of medicine featured in the activity. These relationships are described below.
Clinical Faculty
Kellie Bunn, PA-C, MHS (Chair)
Retained Consultant: Ironwood Pharmaceuticals, Inc
Brooks D. Cash, MD
Retained Consultant: Salix Pharmaceuticals, Inc, IM HealthScience®, Prometheus Laboratories Inc, Ironwood Pharmaceuticals, Inc
Speakers Bureau: Takeda Pharmaceutical Company Ltd, Allergan, Inc, AstraZeneca
Lucinda A. Harris, MD, MS
Grant/Research Support: Alvine Pharmaceuticals Inc., Rhythm Pharmaceuticals
Retained Consultant: Salix Pharmaceuticals, Inc, Allergan, Inc
Speakers Bureau: QOL Medical, LLC, Synergy Pharmaceuticals Inc, Ironwood Pharmaceuticals, Inc
Patient Faculty
Gail S. Cobb
No financial relationships to disclose.
Carly Herbert
No financial relationships to disclose.
Paradigm Medical Communications, LLC staff members have no financial relationships to disclose.
Independent peer reviewers have no financial relationships to disclose.
Resolution of Conflict of Interest
Paradigm Medical Communications, LLC has implemented a system to resolve conflicts of interest for each CME activity to help ensure content objectivity, independence, fair balance, and that the content is aligned with the interest of the public. Conflicts, if any, are resolved through one or more processes. All CME content in this activity was independently reviewed to ensure that it is free of commercial bias, scientifically rigorous, aligned with the public interest, and compliant with all regulatory guidance and the AAPA and ACCME’s Standards for Commercial Support of Continuing Medical Education.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA.
This CME activity represents the views and opinions of the individual faculty, and does not constitute the opinion or endorsement of, or promotion by, Paradigm Medical Communications, LLC. Reasonable efforts have been taken to present educational subject matter in a balanced, unbiased fashion, and in compliance with regulatory requirements. However, each activity participant must always use his or her own personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses.

If included, signed statements of informed consent granting permission for publication have been obtained for all photographs and videos in which an individual can be identified.
As an ACCME-accredited provider, Paradigm Medical Communications, LLC activities must include a balanced view of therapeutic options. Use of generic names contributes to this impartiality. The use of trade names should not be viewed as an endorsement of specific products by Paradigm Medical Communications, LLC.
Terms of Use and Privacy Policy
The materials provided for this activity are for informational purposes only, and should not be used for diagnosis or treatment of a health problem without consulting a licensed medical professional. Any views or opinions presented are solely those of the Faculty, and do not necessarily represent those of Paradigm Medical Communications, LLC. References to any entity, product, service, or source of information on this website should not be considered an endorsement, either direct or implied, by Paradigm Medical Communications, LLC. Paradigm Medical Communications, LLC accepts no liability for the content referenced in this activity.
Privacy policy
Paradigm Medical Communications, LLC is committed to protecting the privacy of those who participate in the activities (herein referred to as "website") located at The information below describes the security of the website for safeguarding personal information and the rationale for collection and use of personal information.
Security/safeguarding personal information
This website has physical and procedural safeguards in place to prevent unauthorized access to personal information used to access this website.
Collection and use of your personal information
The submission of certain personally identifiable information is necessary to award and track the credits participants may earn after completing the program. Required items include first name, last name, degree, and email address. These items are necessary. Participants are also required to complete an evaluation of the CME activity. All evaluative information submitted is collected and retained, and used by Paradigm Medical Communications, LLC to continuously improve the learning experience.
Paradigm Medical Communications, LLC does not transfer, sell, or share personal information with outside parties. Paradigm Medical Communications, LLC will not otherwise disclose personal information unless required to in a legal process. Paradigm Medical Communications, LLC staff members review individual test results to the extent necessary to record and track participants’ credits.
Contact Us
If you have any questions or comments, please email us at
©2015 Paradigm Medical Communications, LLC, except where noted. Content may not be reproduced in whole or part without the express written permission of Paradigm Medical Communications, LLC.